{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2024-06-20T00:00:00", "title": "AO 24-04", "url": "https://oig.hhs.gov/compliance/advisory-opinions/24-04/", "attachments": [{"title": "Advisory Opinion 24-04", "url": "https://oig.hhs.gov/documents/advisory-opinions/9915/AO-24-04.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-24-04", "subagency": "Office of the Inspector General", "summary": "Favorable opinion regarding: (i) a limited-time program to refund, waive, or delay requiring receipt of payment for a drug in the event of an insurance reimbursement denial or delay; and (ii) certain discounts to the cost of the drug."}